Q3 25 EPS
$-0.28
BEAT +8.94%
Est. $-0.31
Q3 25 Revenue
$626.4M
BEAT +0.06%
Est. $626.1M
vs S&P Since Q3 25
-11.1%
TRAILING MARKET
TDOC -3.2% vs S&P +7.9%
Market Reaction
Did TDOC Beat Earnings? Q3 2025 Results
Teladoc Health edged past Wall Street's expectations in Q3 2025, posting a loss of $0.28 per share against a consensus estimate of $0.31 and reporting revenue of $626.44 million, a narrow beat of just 0.06% but still a 2.2% decline from the year-ago … Read more Teladoc Health edged past Wall Street's expectations in Q3 2025, posting a loss of $0.28 per share against a consensus estimate of $0.31 and reporting revenue of $626.44 million, a narrow beat of just 0.06% but still a 2.2% decline from the year-ago period. The headline story remained the structural tension within the business: Integrated Care grew 2% to $389.54 million while BetterHelp, the direct-to-consumer therapy segment, slid 8% to $236.90 million as it navigates a deliberate transition toward insurance acceptance that has compressed its adjusted EBITDA margin to just 1.6%. The net loss widened to $49.51 million, partly reflecting a $12.63 million goodwill impairment charge tied to the Telecare Australia acquisition. With the company already drawing attention for its pivot toward AI-driven virtual care solutions, management is betting that strategic reinvestment will stabilize the platform, guiding Q4 revenue of $622 million to $652 million and full-year free cash flow of $170 million to $185 million.
Key Takeaways
- • Integrated Care segment revenue grew 2% driven by 9% increase in U.S. Integrated Care Members to 102.5 million
- • International revenue grew 12% year-over-year to $116.7 million
- • Other revenue increased 24% year-over-year to $105.5 million
- • Stock-based compensation expense decreased significantly from $34.0 million to $17.0 million
TDOC YoY Financials
Q3 2025 vs Q3 2024, source: SEC Filings
TDOC Revenue by Segment
With YoY comparisons, source: SEC Filings
TDOC Revenue by Geography
With YoY comparisons, source: SEC Filings
“In the third quarter, we again delivered consolidated revenues and adjusted EBITDA in the upper half of our guidance ranges, reflecting consistent execution along with our steadfast commitment to serving our clients and members. Looking ahead we remain focused on advancing important work across each of our strategic priorities, including growth initiatives to drive greater value and impact within our Integrated Care segment and the ongoing rollout of insurance acceptance in BetterHelp.”
— Chuck Divita, Q3 2025 Earnings Press Release
TDOC Earnings Trends
TDOC vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
TDOC EPS Trend
Earnings per share: estimate vs actual
TDOC Revenue Trend
Quarterly revenue: estimate vs actual
TDOC Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 | — | — | — | — | — |
| Q4 25 BEAT FY | $-0.22 | $-0.14 | +35.19% | $642.3M | +1.09% |
| FY Full Year | $-0.99 | $-1.14 | -14.92% | $2.53B | +0.27% |
| Q3 25 BEAT | $-0.31 | $-0.28 | +8.94% | $626.4M | +0.06% |
| Q2 25 BEAT | $-0.31 | $-0.19 | +38.71% | $631.9M | +1.46% |
| Q1 25 MISS | $-0.36 | $-0.53 | -48.04% | $629.4M | +1.64% |